Compare HALO & AVTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HALO | AVTR |
|---|---|---|
| Founded | 1998 | 1904 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.8B | 6.0B |
| IPO Year | 2001 | 2019 |
| Metric | HALO | AVTR |
|---|---|---|
| Price | $63.56 | $7.91 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 11 | 14 |
| Target Price | ★ $78.18 | $12.89 |
| AVG Volume (30 Days) | 1.8M | ★ 10.8M |
| Earning Date | 05-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 2.56 | N/A |
| Revenue | $151,862,000.00 | ★ $6,552,200,000.00 |
| Revenue This Year | $28.24 | $1.10 |
| Revenue Next Year | $12.79 | $1.90 |
| P/E Ratio | $26.00 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $47.50 | $7.91 |
| 52 Week High | $82.22 | $17.11 |
| Indicator | HALO | AVTR |
|---|---|---|
| Relative Strength Index (RSI) | 29.05 | 22.91 |
| Support Level | $63.85 | N/A |
| Resistance Level | $65.40 | $14.29 |
| Average True Range (ATR) | 1.85 | 0.32 |
| MACD | -0.67 | -0.01 |
| Stochastic Oscillator | 1.18 | 1.56 |
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.
Avantor Inc provides products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company operates through two segments: Laboratory Solutions and Bioscience Production. It offers materials & consumables, equipment & instrumentation, and services & specialty procurement. Product groups include Equipment & Instrumentation, Services & Specialty Procurement, Proprietary Materials & Consumables, and Third-Party Materials & Consumables. Materials & consumables include high-purity chemicals and reagents, lab supplies, customized excipients, single-use assemblies, chromatography products, sample preparation kits, and fluid handling solutions. It operates in the Americas, Europe, and AMEA.